Additional Holter and Telemetry Equipment Introduced

Posted:
7
January 2005

As demand for our QTc studies grows, we recently introduced new Holter and Telemetry equipment to enhance this crucial new service.When evaluating new medicines during early phase clinical trials, it is crucial that the impact on the cardiovascular system is monitored continuously. Furthermore, the demand for QTc studies has increased due to undesired side-effects of medicines that prolong cardiac repolarization such as pimozide, thioridazine and cisapride.Ambulatory Holter monitoring as well as continuous Telemetry ECG monitoring are the two new services that we provide at Richmond complementing our QTc Study set up.Our Holter monitors allow the recording of ambulatory ECGs over a continuous period up to 48 hours, whilst not disturbing the normal daily routine of our volunteers. In addition, using our Telemetry system, volunteers are monitored 24 hours a day, 7 days a week whilst in the research unit.Having a dedicated team of Research Physicians who, in conjunction with Cardiologists from the St George's Hospital Medical School, constantly monitor the volunteers enables immediate access to volunteer information and helping to speed analysis and any necessary action.At Richmond Pharmacology we are dedicated to the well being and safety of volunteers. We continue to make every effort acquiring the latest technology to provide our clients with excellent clinical trial services.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.
Read more

A new era for UK-Japanese scientific relations

March 23, 2021
Dr Taubel uses his experience of conducting more than 60 Japanese bridging studies to explain why the deal is of strategic importance to the UK and highlights the scientific requirements for conducting successful Japanese trials abroad
Read more

Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

February 3, 2021
Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London
Read more